Concepedia

Bradford A. Youngblood

BA

Statistics

Publications

17

Citations

817

H-Index

16

Active since

2014

Affiliations

Allakos (United States)(Current)

Northwestern University

Lurie Children's Hospital

Freie Universität Berlin

Texas Tech University Health Sciences Center

Bradford A. Youngblood is an author at Allakos (United States) specializing in life sciences, immunology, and mast cell activation.

ORCID

Publications per year

2014–2024

17

Publications

17

AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice

Bradford A. Youngblood, Emily C. Brock, John Leung et al. · International Archives of Allergy and Immunology · 2019 · 110 citations · Full text

, , +16

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody

Simon Gebremeskel, Julia Schanin, Krysta M. Coyle et al. · Frontiers in Immunology · 2021 · 108 citations · Full text

, , +17

Siglec-8 antibody reduces eosinophils and mast cells in a transgenic mouse model of eosinophilic gastroenteritis

Bradford A. Youngblood, Emily C. Brock, John Leung et al. · JCI Insight · 2019 · 105 citations · Full text

, , +17

A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation

Julia Schanin, Simon Gebremeskel, Wouter Korver et al. · Mucosal Immunology · 2020 · 75 citations · Full text

, , +17

Sialic acid–binding immunoglobulin-like lectin (Siglec) 8 in patients with eosinophilic disorders: Receptor expression and targeting using chimeric antibodies

Fanny Legrand, Yun Cao, Joshua B. Wechsler et al. · Journal of Allergy and Clinical Immunology · 2018 · 59 citations · Full text

, , +16

1–5 of 17